文献速递牙周病牙体牙髓病

多组分牙周治疗对糖尿病合并牙周炎患者口腔及代谢指标影响的年龄差异:一项meta流行病学研究

Age differences in the effects of multi-component periodontal treatments on oral and metabolic health among people with diabetes mellitus: A meta-epidemiological study.
PubMed 文献 · J Dent · 2023-06-22

该meta流行病学研究纳入115项试验(119篇文章),受试者平均年龄58岁(35-73岁),探讨多组分牙周治疗对伴糖尿病牙周炎患者探诊深度(PD)、临床附着水平(CAL)和糖化血红蛋白(HbA1c)影响的年龄差异。结果显示治疗显著改善PD(g=0.929)、CAL(g=0.879)和HbA1c(g=0.603),且年龄越大效应量越小。结论提示多组分牙周治疗对年轻人群可能更有效。

要点

  • 多组分牙周治疗可显著降低PD、CAL和HbA1c。
  • 年龄增长与PD和CAL效应量减小显著相关。
  • 55岁及以上患者HbA1c改善效应量较小。

核心结论

  • 多组分牙周治疗对伴糖尿病牙周炎患者在PD、CAL和HbA1c上均有显著改善,但年龄越大效应量越小,年轻人群可能更有效。

研究设计与样本

  • meta流行病学研究,检索6个数据库至2022年8月,纳入115项试验(119篇文章),受试者年龄≥18岁且伴牙周炎和糖尿病,平均年龄58岁(范围35-73岁)。

主要发现

  • 多组分牙周治疗显著降低PD(g=0.929 [0.689-1.169],I²=94.1%)、CAL(g=0.879 [0.669-1.089],I²=92.1%)和HbA1c(g=0.603 [0.443-0.763],I²=87.5%)。
  • 随年龄增加,PD(P for trend=0.020)和CAL(P for trend=0.028)的效应量呈显著下降趋势。
  • 多变量meta回归显示,平均年龄与PD(β=-0.123 [0.041],P=0.004)和CAL(β=-0.159 [0.055],P=0.006)的较小效应量相关。
  • 与年轻者相比,55岁及以上参与者的HbA1c效应量较小(β=-0.792 [0.322],P=0.017)。

临床怎么用

  • 制定牙周治疗方案时应考虑患者年龄,对老年患者可能需要更积极或个性化策略以达到最佳效果。
  • 强调早期干预的重要性,年轻患者可能从多组分牙周治疗中获得更大的口腔和代谢获益。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To explore the age differences in the effects of multi-component periodontal treatments on oral and metabolic indicators among individuals with periodontitis and diabetes. DATA: Trials reporting the effects of multi-component periodontal treatments on oral and metabolic indicators among participants aged 18 and above with periodontitis and diabetes were included. SOURCES: Six databases (PubMed/Medline, Embase, CINHAL, Web of Science, Cochrane Library, and ProQuest) were searched from database inception to August 2022. STUDY SELECTION: Two reviewers selected the included studies independently. We used bivariate and multivariate meta-regression models to examine the association between age and treatment effect size. The primary outcomes were changes in probing depth (PD), clinical attachment level (CAL), and hemoglobin A1c (HbA1c). RESULTS: A total of 18,067 articles were identified in the database search. Of these, 115 trials (119 articles) met inclusion criteria. The mean age of participants was 58 years old, ranging from 35 to 73 years. The pooled evidence demonstrated that multi-component periodontal treatment significantly reduced PD (g=0.929 [0.689-1.169], I2=94.1%), CAL (g=0.879 [0.669-1.089], I2=92.1%), and HbA1c (g=0.603 [0.443-0.763], I2=87.5%). A significant decreasing trend was observed in the effect size for PD (P for trend = 0.020) and CAL (P for trend = 0.028) as age increases. Results from multivariate meta-regression showed that mean age was associated with a smaller effect size for PD (β=-0.123 [0.041], P = 0.004) and CAL (β=-0.159 [0.055], P = 0.006). Compared to their younger counterparts, the effect size for HbA1c was smaller among participants aged 55 and older (β=-0.792 [0.322], P = 0.017). CONCLUSIONS: Multi-component periodontal treatments may be more effective in younger populations in terms of effects on PD, CAL, and HbA1c. CLINICAL SIGNIFICANCE: Our study highlights the importance of early intervention and tailored treatment approaches. Clinicians should take into account the patient's age when developing periodontal treatment plans and may need to employ more aggressive or personalized strategies for older adults to achieve optimal outcomes.

来源:J Dent,查看原文。版权归原作者所有。

引用

  1. Zhu Z, Qi X, Zheng Y, et al. Age differences in the effects of multi-component periodontal treatments on oral and metabolic health among people with diabetes mellitus: A meta-epidemiological study. J Dent. 2023. PMID: 37355088. doi:10.1016/j.jdent.2023.104594

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。